Examkin

Soru

Zorluk: Çok zorHemodynamic and Coagulation Processes

A 6868-year-old male is evaluated in the intensive care unit on hospital day 66. He was initially admitted for a massive pulmonary embolism and has been receiving a continuous intravenous infusion of unfractionated heparin. Today, routine laboratory studies reveal a precipitous decline in his platelet count from an admission baseline of 240,000/mm3240,000/\text{mm}^3 to 60,000/mm360,000/\text{mm}^3. Concurrently, the patient reports new-onset, severe pain in his right calf. A comprehensive physical examination demonstrates a pale, edematous, and tender right lower extremity. A stat duplex ultrasound confirms an acute deep vein thrombosis in the right popliteal vein. The clinical picture yields a 4T score of 77, indicating a high probability of heparin-induced thrombocytopenia (HIT).

Arrange the following pharmacologic and diagnostic management steps in the strict chronological sequence required to safely treat this patient's coagulopathy and transition him to long-term oral anticoagulation.

  1. 1Discontinue all unfractionated heparin infusions and heparin-coated catheter flushes.
  2. 2Initiate therapeutic anticoagulation with an alternative non-heparin agent, such as argatroban.
  3. 3Monitor daily complete blood counts until the platelet level recovers to at least 150,000/mm3150,000/\text{mm}^3.
  4. 4Commence overlapping oral warfarin therapy at a standard initiation dose.
  5. 5Discontinue the non-heparin parenteral anticoagulant after the INR remains therapeutic for 4848 hours.

Cevap

The correct sequence is: 1) Discontinue all heparin products, 2) Initiate a non-heparin anticoagulant like argatroban, 3) Monitor until platelets recover to ≥150,000/mm3\geq 150,000/\text{mm}^3, 4) Start overlapping warfarin therapy, 5) Stop argatroban when the INR is therapeutic for 4848 hours.
The management of HIT follows a rigid chronological protocol to mitigate the risk of catastrophic thrombosis. Upon suspecting HIT, the inciting agent (heparin) must be stopped to halt the immune cascade. Because patients remain profoundly hypercoagulable, a non-heparin alternative (like argatroban) is immediately required. The timing of warfarin initiation is the most critical subsequent step; it is strictly contraindicated during the acute thrombocytopenic phase due to the rapid depletion of Protein C, which can cause venous limb gangrene. Therefore, the clinician must wait for platelet recovery (≥150,000/mm3\geq 150,000/\text{mm}^3) before overlapping warfarin, and finally discontinue the parenteral agent only after the INR is therapeutic for 4848 hours.

Adım Adım Çözüm

1
Identify the primary diagnosis and its immediate mechanism.
The patient has Heparin-Induced Thrombocytopenia (HIT) with new thrombosis, characterized by IgG antibodies against PF4-heparin complexes causing platelet activation.
Establishing the diagnosis dictates the urgent need to remove the inciting antigen.
2
Determine the first therapeutic intervention.
All heparin exposure must be ceased immediately.
Continuing heparin fuels the catastrophic immune-mediated platelet activation and massive thrombin generation.
3
Address the resulting prothrombotic state and acute deep vein thrombosis.
A non-heparin anticoagulant (e.g., argatroban, bivalirudin, or fondaparinux) is initiated.
HIT is paradoxically a hypercoagulable state; stopping heparin alone is insufficient to prevent thrombus extension or new thromboses.
4
Determine the criteria for transitioning to oral anticoagulation.
Wait for platelet recovery (≥150,000/mm3\geq 150,000/\text{mm}^3), then start warfarin.
Warfarin rapidly decreases Protein C levels. Giving warfarin during acute HIT causes a severe procoagulant shift, leading to venous limb gangrene. Platelet recovery signals that the acute HIT process has subsided.
5
Establish the criteria for stopping the bridging parenteral agent.
Overlap warfarin and argatroban until the INR is therapeutic for at least 4848 hours.
This ensures the long half-life procoagulant factors (like Factor II) are fully suppressed before removing the parenteral protection.

Anahtar Kavram

In Heparin-Induced Thrombocytopenia, warfarin must be strictly avoided until the platelet count has normalized to prevent warfarin-induced skin necrosis and venous limb gangrene.
Bu soruyu puanla

Konular

Hemodynamic and Coagulation Processes

Bu konudan daha fazla soru